Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2000
06/08/2000WO2000032203A1 Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
06/08/2000WO2000032201A2 Use of 17-ketosteroids for the treatment of malaria and trypanosomiasis
06/08/2000WO2000032196A2 Inhibitors of multidrug transporters
06/08/2000WO2000032189A1 Celecoxib compositions
06/08/2000WO2000032178A2 Use of siburamine for the treatment of disorders of the central nervous system secondary to organic impairments
06/08/2000WO2000032177A2 Use of 17-ketosteroids in the treatment of hepatitis c virus and other togavirus infections
06/08/2000WO2000032172A1 An oral formulation for gastrointestinal drug delivery
06/08/2000WO2000032171A2 Autoahesive oral transmucosal delivery dosage form
06/08/2000WO2000032152A2 Compositions and methods for regulating bacterial pathogenesis
06/08/2000WO2000032047A1 Plasmid maintenance system for antigen delivery
06/08/2000WO2000018386A3 Antibiotic compositions for treatment of the eye, ear and nose
06/08/2000WO2000015659A3 Stomach polypeptide zsig28
06/08/2000WO2000014200A3 Essential bacterial genes and their use
06/08/2000WO2000012541A3 Cytotoxic peptides modified by bulky or lipophilic moieties
06/08/2000WO2000012535A3 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
06/08/2000WO2000011183A3 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000009086A3 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
06/08/2000WO2000008191A3 Herpes virus vectors for dendritic cells
06/08/2000WO1999063934A3 Antimicrobial alcohol gel pre-operative skin-preparation delivery systems
06/08/2000DE19856463A1 Retrovirale, mit LCMV pseudotypisierte Hybrid-Vektoren Retroviral pseudotyped with LCMV hybrid vectors
06/08/2000DE19855963A1 Amphiphile Glycerylnucleotide, Verfahren zu ihrer Herstellung und ihre Verwendung Amphiphilic glyceryl, processes for their preparation and their use
06/08/2000DE19855881A1 Verfahren zur Aktivierung von Wasser und Verwendung derartig aktivierten Wassers Process for the activation of water and use of such activated water
06/08/2000CA2356539A1 Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of malaria and the treatment of african and american trypanosomiasis
06/08/2000CA2354183A1 Ordered molecular presentation of antigens, method of preparation and use
06/08/2000CA2353563A1 Development of novel anti-microbial agents based on bacteriophage genomics
06/08/2000CA2353557A1 Inhibitors of multidrug transporters
06/08/2000CA2353499A1 Method for activating water and use of activated water of this type
06/08/2000CA2353107A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000CA2353090A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression
06/08/2000CA2352971A1 Crystalline salts of a carbapenem antibiotic
06/08/2000CA2352759A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000CA2352562A1 Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
06/08/2000CA2352539A1 Recombinant soluble fc receptors
06/08/2000CA2352466A1 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
06/08/2000CA2352459A1 .gamma..delta.t cell immunoactivity enhancers containing extract of lentinus edodes mycelium
06/08/2000CA2352457A1 Plasmid maintenance system for antigen delivery
06/08/2000CA2352454A1 Peptide-based vaccine for influenza
06/08/2000CA2352388A1 A pharmaceutical composition comprising cyclosporin in a lipid carrier
06/08/2000CA2352205A1 Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of hepatitis c virus and other togaviruses
06/08/2000CA2351731A1 Compositions and methods for regulating bacterial pathogenesis
06/08/2000CA2351062A1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
06/08/2000CA2348823A1 New oligomeric conjugates liable to transfer biological molecules into cells
06/08/2000CA2342621A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives
06/07/2000EP1006197A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells
06/07/2000EP1006196A2 Retroviral hybrid vectors pseudotyped with LCMV glycoprotein
06/07/2000EP1006183A1 Recombinant soluble Fc receptors
06/07/2000EP1006178A2 An immortal cell line derived from grouper Epinephelus coioides and its applications
06/07/2000EP1005868A1 Use of alpha interferon and ribavirin in the manufacture of a medicament for combination therapy for chronic hepatitis C infection
06/07/2000EP1005851A1 Cosmetic or dermatological composition comprising at least one alkynyl carbamate and at least one polyol
06/07/2000EP1005493A1 Antiviral protease inhibitors
06/07/2000EP1005469A1 Oxazolidinone derivatives and their use as antibacterial agents
06/07/2000EP1005468A1 Antibiotic oxazolidinone derivatives
06/07/2000EP1005368A1 USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT
06/07/2000EP1005367A2 Vaccines containing bordetella pertussis antigen
06/07/2000EP1005366A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof
06/07/2000EP1005365A1 Abundant extracellular products and methods for their production and use
06/07/2000EP1005364A1 Method of protecting against chronic infections
06/07/2000EP1005363A2 Recombinant dimeric envelope vaccine against flaviviral infection
06/07/2000EP1005356A1 Novel antibacterial agents
06/07/2000EP1005351A1 An aqueous metal bicarbonate solution and method of use
06/07/2000EP1005342A1 Pharmaceutical compositions of tizoxanide and nitazoxanide
06/07/2000EP1005338A1 Substituted aurone derivatives
06/07/2000EP1005267A1 Phototherapy based method for treating pathogens and composition for effecting same
06/07/2000EP0840606B1 Di- and trivalent small molecule selectin inhibitors
06/07/2000EP0773025B1 New stable galenic formulations containing an acid-labile benzimidazol compound, and production process
06/07/2000CN1255861A Multivalent vaccine compsn. with mixed carrier
06/07/2000CN1255859A Pharmaceutical antiviral compsn. comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
06/07/2000CN1255853A Medical compsns. against helicobacter pylori
06/07/2000CN1255849A Medical compsns.
06/07/2000CN1255494A Polyacetyl acetogenins for eliminating HIV virus and treating AIDS
06/07/2000CN1255373A Medicine for treating multiple skin diseases and its preparing process
06/07/2000CN1255359A Medicine prepared from humid euphorbia for treating beriberi
06/07/2000CN1255355A Process for extracting from active parts of suffrutescent securinega and its application for preventing and treating AIDS
06/07/2000CN1255354A Process for preparing injection to treat pulmonary tuberculosis
06/07/2000CN1053188C Quinolizinone type compounds
06/07/2000CN1053182C Novel 9-amino-7-substituted-6-demethyl-6-deoxytetracyclines, its prepn. process and compsns. thereof
06/06/2000US6072051 Viricide against hepatitis b virus with low toxicity
06/06/2000US6072049 Hepatitis B surface antigen vaccine
06/06/2000US6072045 Chimeric isoprenoid synthases and uses thereof
06/06/2000US6072032 Amino acid sequence of polypeptide involved in protein secretory apparatus of bacteria; for screening for bactericides and bacteriostats; diagnosis of and prophylaxis for infections
06/06/2000US6071972 Useful for disinfecting or sterilizing medical devices or environmental surfaces
06/06/2000US6071961 For treating gastritis caused by caphylobacteria by administeing microbiocide comprising aliphatic or aromatic fatty acid, hydrotope and compatible acid
06/06/2000US6071948 Treatment of diseases caused by excessive blood vessel growth
06/06/2000US6071942 Elevation of circulating blood histamine levels
06/06/2000US6071919 Stimulate the immunological system and to induce the production of hypercellular bone marrow and extramedullary hematopoiesis; antitumor and -carcinogenic agents; autoimmune diseases; viricides; hepatitis
06/06/2000US6071906 Inhibits or modulates the inducible isoform of nitric oxide synthase over the the constitutive isoforms; antiarthritic, -diabetic, ischemic, thrombosis agents; cardiovascular disorders; toxic shock syndrome; autoimmune diseases
06/06/2000US6071905 Treating tuberculosis, mycobacteriosis, viral and immune diseases, chlamydia infections, antitumor and -carcinogenic agents; microbiocides, in particular to mycobacteria resistant to isoniazide; stimulantes interferons
06/06/2000US6071894 Sensor histidine kinase of Staphylococcus aureus
06/06/2000US6071892 Polynucleotides that encode the polypeptide of tyrosyl synthetase have amino acid homology to a known bacillus subtilis tyrosyl trna synthetase protein
06/06/2000US6071886 β,β-distributed derivatives of 9-deoxo-9a-N-ethenyl-9a-aza-9a-homoerythromycin A
06/06/2000US6071743 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
06/06/2000US6071742 Coxsackie virus as a vector for delivery of anti-inflammatory cytokines
06/06/2000US6071737 Equine Neospora isolate and its uses
06/06/2000US6071731 Enzymatic polypeptide for the attachment of histidine to transfer ribonucleic acid molecule; bactericides; wound healing agents
06/06/2000US6071722 Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
06/06/2000US6071692 Inserting exogenous genes into cells; inserting gene into plasmid and transforming cell
06/06/2000US6071523 Oral administering from squeezable container; storage stability, heat resistance; drug delivery
06/06/2000US6071520 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
06/06/2000US6071516 Administering normal gamma-globulin
06/06/2000CA2101466C Taste-masking composition of bitter pharmaceutical agents
1 ... 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 ... 1798